/ /

Vanessa Caceres
Early intervention considered key in diagnosis and treatment of scleritis
Scleritis can indicate serious systemic disease and requires prompt diagnosis and treatment. Episcleritis also has certain treatment pearls.
Immunomodulatory therapy for corneoscleral disease requires careful monitoring
Immunomodulatory therapy for ocular inflammatory disease can be potent and effective, but physicians should be patient while awaiting results—and watch carefully for complications.
Dexamethasone for DME shows stronger results compared with sham group
Use of an intravitreal implant for diabetic macular edema was more effective than a sham treatment across a variety of parameters in a subanalysis of the MEAD trial.
Use of Bowman layer implantation promising for advanced keratoconus
Results were encouraging from patients in a small study group receiving Bowman layer implantations to treat advanced keratoconus.
What to say when discussing MIGS with patients
When microinvasive glaucoma surgery is a potential treatment option, surgeons should present it as neutrally as possible.
Switching treatments for wet AMD poses numerous complexities
Switching treatments for wet AMD poses numerous complexities
Studies that focus on switching treatments for exudative age-related macular degeneration may represent more real-life scenarios. However, future prospective studies with predetermined switching criteria and follow-up are needed.
Animal model connects gene mutation and normal-tension glaucoma
Transgenic mice engineered to have extra copies of the TBK1 gene showed effects similar to those in human patients with normal-tension glaucoma, providing clues to pathophysiology and potential treatments.
5 pearls to manage white cataracts
Better management of white cataracts with these pearls can help avoid complications like the Argentinian flag sign.
Pseudoexfoliation syndrome not yet ready for genetic testing
Although the LOXL1 gene may increase the risk for pseudoexfoliation syndrome, currently available genetic testing does not effectively predict who will develop disease.
Levodopa for amblyopia explored as novel modality
A study of children with residual amblyopia did not find an advantage with the use of levodopa compared with a placebo group.

Poll

View Results